Effect of heparin on the biological properties and molecular signature of human mesenchymal stem cells
Author
dc.contributor.author
Ling, Ling
Author
dc.contributor.author
Camilleri, Emily T.
Author
dc.contributor.author
Helledie, Torben
Author
dc.contributor.author
Samsonraj, Rebekah M.
Author
dc.contributor.author
Titmars, Drew M.
Author
dc.contributor.author
Chua, Ren Jie
Author
dc.contributor.author
Dreesen, Oliver
Author
dc.contributor.author
Dombrowski, Christian
Author
dc.contributor.author
Rider, David A.
Author
dc.contributor.author
Galindo Diaz, Mario
Author
dc.contributor.author
Lee, Ian
Author
dc.contributor.author
Hong, Wanjin
Author
dc.contributor.author
Hui, James H.
Author
dc.contributor.author
Nurcombe, Victor
Author
dc.contributor.author
van Wijnen, Andre J.
Author
dc.contributor.author
Cool, Simon M.
Admission date
dc.date.accessioned
2016-06-14T13:35:59Z
Available date
dc.date.available
2016-06-14T13:35:59Z
Publication date
dc.date.issued
2016
Cita de ítem
dc.identifier.citation
Gene 576 (2016) 292–303
en_US
Identifier
dc.identifier.other
DOI: 10.1016/j.gene.2015.10.039
Identifier
dc.identifier.uri
https://repositorio.uchile.cl/handle/2250/138792
General note
dc.description
Artículo de publicación ISI
en_US
Abstract
dc.description.abstract
Chronic use of heparin as an anti-coagulant for the treatment of thrombosis or embolism invokes many adverse systemic events including thrombocytopenia, vascular reactions and osteoporosis. Here, we addressed whether adverse effects might also be directed to mesenchymal stem cells that reside in the bone marrow compartment. Harvested human bone marrow-derived mesenchymal stem cells (hMSCs) were exposed to varying doses of heparin and their responses profiled. At low doses (<200 ng/ml), serial passaging with heparin exerted a variable effect on hMSC proliferation and multipotentiality across multiple donors, while at higher doses 100 mu g/ml), heparin supplementation inhibited cell growth and increased both senescence and cell size. Gene expression profiling using cDNA arrays and RNA-seq analysis revealed pleiotropic effects of low-dose heparin on signaling pathways essential to hMSC growth and differentiation (including the TGFS/BMP superfamily, FGFs, and Wnts). Cells serially passaged in low-dose heparin possess a donor-dependent gene signature that reflects their altered phenotype. Our data indicate that heparin supplementation during the culturing of hMSCs can alter their biological properties, even at low doses. This warrants caution in the application of heparin as a culture supplement for the ex vivo expansion of hMSCs. It also highlights the need for careful evaluation of the bone marrow compartment in patients receiving chronic heparin treatment.
en_US
Patrocinador
dc.description.sponsorship
National Medical Research Council of Singapore
NMRC/1257/2010; National Institutes of Health
AR49069